| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Quest Diagnostics said Monday that it will offer consumer-initiated lab testing in collaboration with Walmart. Quest said it is making more than 50 tests, including those for general health, digestive health, allergy, heart health, women's health, and infectious disease, available at Walmart.com through its QuestDirect service.
Clinical laboratory Quest Diagnostics is launching an at-home COVID-19 rapid antigen test service that can certify results 24/7 via telehealth. The service enables the 15-minute self-administered Abbott BinaxNow COVID-19 home test to be used under observation from a certified telehealth proctor.
Quest Diagnostics will acquire the patient engagement company Pack Health, the organizations announced. "Quest Diagnostics and Pack Health have complementary capabilities that, when combined, will strengthen our ability to help health plans and other risk-bearing organizations deliver value-based care," Dermot Shorten, senior vice president of strategy, mergers and acquisitions, and ventures at Quest Diagnostics, wrote in an email.
Harvey Kaufman, MD, MBA, senior medical director at Quest Diagnostics, led a study for the company examining the impact of COVID-19 on prostate cancer screening and diagnoses. The results of the study are part of Quest Diagnostics Health Trends, which he has been involved with since it began in 2005 and now leads. CLP sat down with Kaufman prior to the Omicron surge to discuss the findings of the study and about the future of diagnostic testing in general.
Quest Diagnostics signaled an upbeat 2021 profit as COVID-19 testing volumes surged with the spread of the Omicron coronavirus variant in the United States. Quest said it performed over 120,000 PCR tests per day in the last couple of weeks of 2021, and over 150,000 tests a day at the beginning of this year.
At-home COVID-19 antigen tests are in high demand, and for good reason. They're quick, convenient, and can help you contain the spread of the infection. That said, the FDA has acknowledged that certain rapid antigen tests may be less sensitive to the Omicron variant, prompting speculation that there's got to be a better way. "As more countries continue the double-swab method, it may impact future FDA and CDC guidelines for those of us in the US. But it's important to reiterate that this method is currently not authorized by the FDA," says Jeffrey Dlott, MD, the medical director of consumer health at Quest Diagnostics, which conducts testing for COVID-19 and other infectious diseases.
Quest Diagnostics, a diagnostic information services provider based in New Jersey, announced Dec. 14 it has acquired Labtech Diagnostics, an independent clinical diagnostic laboratory provider in Anderson, for an undisclosed sum.
A study published in JAMA Pediatrics this fall suggested that more than half of all US children have detectable levels of lead in their blood – and that elevated blood lead levels were closely associated with race, poverty and living in older housing. “Most American children are exposed to lead, a substance that is not safe at any level,” said co-author Dr Harvey Kaufman, a senior medical director at Quest Diagnostics, which led the study.
On Monday, scientists reported that blood pressure measurements of nearly a half-million adults showed a significant rise last year, compared with the previous year. A new study, by researchers at the Cleveland Clinic and Quest Diagnostics, examined data from hundreds of thousands of employees and family members in wellness programs that tracked blood pressure and other health indicators, like weight.
Quest Diagnostics recently released its latest Health Trends report, Drug Misuse in America 2021: Physician Perspectives and Diagnostic Insights on the Drug Crisis and COVID-19, conducted by the Harris Poll, which reveals physicians' worries and fears about recognizing addiction and affects of the pandemic on people who use drugs.
At the beginning of the pandemic, patients nationwide canceled doctor’s visits for a range of medical issues as public health authorities recommended delaying non-urgent in-person medical care. During this time, clinical drug testing by Quest Diagnostics plummeted by 70%, while contributors to substance use disorders like job loss, economic hardship, and mental health issues soared.
Those lucky enough to be traveling to Hawaii for the holidays are required to get a pre-travel COVID-19 test prior to departure to avoid being required to quarantine upon arrival. Secaucus-based Quest Diagnostics says it can help in that effort. Quest was recently named a trusted lab partner for COVID-19 testing services by the state of Hawaii for its Trusted Testing and Travel Partners Program.
Thousands of vials arrive via couriers every day to a new Quest Diagnostics laboratory in Clifton. They flood into the Passaic County facility from doctors, medical clinics in six states and Hackensack Meridian Health facilities in New Jersey. The sheer volume of the operation speaks to the importance of the medical diagnostics field.
Three-fourths of physicians said they believe telemedicine visits limit their ability to determine whether patients are at risk for or are currently misusing prescription drugs, according to a new study. Providers are concerned that substance abuse issues are slipping through the cracks in virtual care, as patients experience more stress and mental illness, according to the 2021 Quest Diagnostics Health Trends report released in November.
With the legalization of recreational marijuana in New York earlier this year, most employers cannot penalize job applicants or employees for marijuana use off-duty. But in states across the country, with labor shortages, changing laws and evolving attitudes, fewer companies are testing for marijuana. The rate at which marijuana was being included in urine drug testing declined 5.2% in the United States between 2015 and 2020, said Barry Sample, senior director of science and technology at Quest Diagnostics, which performs more than 10 million drug tests annually.
Quest Diagnostics, a diagnostics services provider in oncology and genetics, has announced that it will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.
The New York City-based startup recently launched a new partnership with Quest Diagnostics and brought on Devon Kennard, an American football linebacker for the Arizona Cardinals of the National Football League (NFL), as an investor in the company.
Quest Diagnostics Inc. has completed the consolidations of its Northeast regional operations into its new, 250,000-square-foot facility at ON3 in Clifton, it announced Tuesday. The Secaucus-based diagnostic testing company said in a news release that the lab will serve more than 40 million people per year in seven states, increasing productivity and capacity. It is capable of more than 300,000 tests per day thanks to extensive automation, the company noted.
Steve Rusckowski, Chairman and CEO of Quest Diagnostics, discusses opening a highly automated diagnostic testing facility in New Jersey.
Meg Tirrell joins The Exchange with Quest Diagnostics CEO Steve Rusckowski to discuss the future of Covid testing. As the flu and cold seasons return, Rusckowski says, he expects more people will turn up to Covid testing when they present symptoms that are similar to those of Covid, the flu and the common cold.
Laboratory testing is the backbone of many clinical decisions. Laboratory stewardship helps ensure testing is used for the right patients when it is truly needed. By Lee Hilborne, MD, MPH, Senior Corporate Medical Director, Quest Diagnostics.
An interview with Steve Rusckowski, chairman, chief executive officer and president of Quest Diagnostics. In 2020 the company launched Quest for Health Equity (Q4HE), an over $100 million initiative focused on addressing inequities in health care that affect underserved populations across the U.S. Quest serves half of the hospitals and one-third of the U.S. population annually. The company provides results for nearly two million tests daily, ranging from routine testing to breakthrough genetic testing.
U.S. health regulators authorized the use of the first artificial-intelligence tool designed to help doctors diagnose prostate cancer. The tool, Paige Prostate from New York startup Paige.AI Inc., analyzes digital scans of prostate biopsy slides and compares them against data sets of cell and tissue patterns previously identified as indicators of tumors. Quest Diagnostics Inc., which operates medical testing labs across the U.S., has tested Paige Prostate at its AmeriPath Inc. pathology unit and plans to use the software across various sites as soon as October, said Kristie Dolan, general manager of Quest’s oncology franchise operation.
About half of young children who were tested for lead had detectable levels of the toxic metal in their blood, according to a new study published in the peer-reviewed journal JAMA Pediatrics on Monday. The new study is the first to examine low levels of lead in children’s blood, enabled by more sensitive technology, said Harvey Kaufman, a co-author of the study. Kaufman is also senior medical director at Quest Diagnostics Inc., which performed the testing for the study.
Last week, Quest Diagnostic DGX issued its periodical media statement on the company’s COVID-19 testing-related business performance. The company noted a dramatic increase in testing demand through July to September, as the United States is seeing a surge in the Delta variant-led cases.